GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannovum Cannabis AG (XTER:27N0) » Definitions » FCF Margin %

Cannovum Cannabis AG (XTER:27N0) FCF Margin % : 0.00% (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Cannovum Cannabis AG FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Cannovum Cannabis AG's Free Cash Flow for the six months ended in Jun. 2024 was €0.00 Mil. Cannovum Cannabis AG's Revenue for the six months ended in Jun. 2024 was €0.00 Mil. Therefore, Cannovum Cannabis AG's FCF Margin % for the quarter that ended in Jun. 2024 was 0.00%.

As of today, Cannovum Cannabis AG's current FCF Yield % is 0.00%.

The historical rank and industry rank for Cannovum Cannabis AG's FCF Margin % or its related term are showing as below:


XTER:27N0's FCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.87
* Ranked among companies with meaningful FCF Margin % only.


Cannovum Cannabis AG FCF Margin % Historical Data

The historical data trend for Cannovum Cannabis AG's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannovum Cannabis AG FCF Margin % Chart

Cannovum Cannabis AG Annual Data
Trend Dec20 Dec21 Dec22 Dec23
FCF Margin %
- - - -

Cannovum Cannabis AG Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
FCF Margin % Get a 7-Day Free Trial Premium Member Only - - - - -

Competitive Comparison of Cannovum Cannabis AG's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Cannovum Cannabis AG's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannovum Cannabis AG's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannovum Cannabis AG's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Cannovum Cannabis AG's FCF Margin % falls into.


;
;

Cannovum Cannabis AG FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Cannovum Cannabis AG's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=0/0.004
=0.00 %

Cannovum Cannabis AG's FCF Margin for the quarter that ended in Jun. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannovum Cannabis AG FCF Margin % Related Terms

Thank you for viewing the detailed overview of Cannovum Cannabis AG's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannovum Cannabis AG Business Description

Traded in Other Exchanges
Address
Rheinsberger Street 76/77, Berlin, BB, DEU, 10115
Cannovum Cannabis AG is a fully licensed pharmaceutical wholesaler, importer, and manufacturer of high-quality medical cannabis products based in Berlin. It focuses on the import of medical cannabis, medical-scientific education, and distribution for facilitated access to cannabis-based therapies.

Cannovum Cannabis AG Headlines

No Headlines